IDEAS home Printed from https://ideas.repec.org/h/elg/eechap/13300_5.html
   My bibliography  Save this book chapter

Global Bioregions: Knowledge Domains, Capabilities and Innovation System Networks

In: The Capitalization of Knowledge

Author

Listed:
  • Philip Cooke

Abstract

This ground-breaking new volume evaluates the capacity of the triple helix model to represent the recent evolution of local and national systems of innovation. It analyses both the success of the triple helix as a descriptive and empirical model within internationally competitive technology regions as well as its potential as a prescriptive hypothesis for regional or national systems that wish to expand their innovation processes and industrial development. In addition, it examines the legal, economic, administrative, political and cognitive dimensions employed to configure and study, in practical terms, the series of phenomena contained in the triple helix category.

Suggested Citation

  • Philip Cooke, 2010. "Global Bioregions: Knowledge Domains, Capabilities and Innovation System Networks," Chapters, in: Riccardo Viale & Henry Etzkowitz (ed.), The Capitalization of Knowledge, chapter 5, Edward Elgar Publishing.
    • Handle: RePEc:elg:eechap:13300_5
    as

    Download full text from publisher

    File URL: https://www.elgaronline.com/view/9781848441149.00013.xml
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Walter Powell & Kenneth Koput & James Bowie & Laurel Smith-Doerr, 2002. "The Spatial Clustering of Science and Capital: Accounting for Biotech Firm-Venture Capital Relationships," Regional Studies, Taylor & Francis Journals, vol. 36(3), pages 291-305.
    2. Orsenigo, L. & Pammolli, F. & Riccaboni, Massimo, 2001. "Technological change and network dynamics: Lessons from the pharmaceutical industry," Research Policy, Elsevier, vol. 30(3), pages 485-508, March.
    3. Steven Casper;Hannah Kettler, 2000. "The Road to Sustainability in the UK and German Biotechnology Industries," Monograph 000466, Office of Health Economics.
    4. Lars Coenen & Jerker Moodysson & Bjørn T. Asheim, 2004. "Nodes, networks and proximities: on the knowledge dynamics of the Medicon Valley biotech cluster," European Planning Studies, Taylor & Francis Journals, vol. 12(7), pages 1003-1018, June.
    5. Philip Cooke, 2003. "The Evolution of Biotechnology in Three Continents: Schumpeterian or Penrosian?," European Planning Studies, Taylor & Francis Journals, vol. 11(7), pages 757-763, October.
    6. Zucker, Lynne G & Darby, Michael R & Armstrong, Jeff, 1998. "Geographically Localized Knowledge: Spillovers or Markets?," Economic Inquiry, Western Economic Association International, vol. 36(1), pages 65-86, January.
    7. Maryann P. Feldman & Johanna L. Francis, 2003. "Fortune Favours the Prepared Region: The Case of Entrepreneurship and the Capitol Region Biotechnology Cluster," European Planning Studies, Taylor & Francis Journals, vol. 11(7), pages 765-788, October.
    8. Robert Kaiser, 2003. "Multi-level Science Policy and Regional Innovation: The Case of the Munich Cluster for Pharmaceutical Biotechnology," European Planning Studies, Taylor & Francis Journals, vol. 11(7), pages 841-857, October.
    9. Garri Raagmaa & Priit Tamm, 2004. "An emerging biomedical business in a low capitalised country," European Planning Studies, Taylor & Francis Journals, vol. 12(7), pages 943-960, June.
    10. Helen Lawton Smith & Sharmistha Bagchi-Sen, 2004. "Innovation Geographies: International Perspectives on Research, Product Development, and Commercialisation of Biotechnologies," Environment and Planning C, , vol. 22(2), pages 159-160, April.
    11. Mowery,David C. & Nelson,Richard R. (ed.), 1999. "Sources of Industrial Leadership," Cambridge Books, Cambridge University Press, number 9780521645201.
    12. Steven Casper & Anastasios Karamanos, 2003. "Commercializing Science in Europe: The Cambridge Biotechnology Cluster," European Planning Studies, Taylor & Francis Journals, vol. 11(7), pages 805-822, October.
    13. Philip Cooke, 2005. "Rational drug design, the knowledge value chain and bioscience megacentres," Cambridge Journal of Economics, Cambridge Political Economy Society, vol. 29(3), pages 325-341, May.
    14. Jorge Niosi & Tomas G. Bas, 2003. "Biotechnology Megacentres: Montreal and Toronto Regional Systems of Innovation," European Planning Studies, Taylor & Francis Journals, vol. 11(7), pages 789-804, October.
    15. Jason Owen-Smith & Walter W. Powell, 2004. "Knowledge Networks as Channels and Conduits: The Effects of Spillovers in the Boston Biotechnology Community," Organization Science, INFORMS, vol. 15(1), pages 5-21, February.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Franz Tödtling & Michaela Trippl & Joshua von Gabain, 2006. "Clusterentwicklung und -politik im Biotechnologiesektor Wien im Kontext internationaler Erfahrungen," SRE-Disc sre-disc-2006_02, Institute for Multilevel Governance and Development, Department of Socioeconomics, Vienna University of Economics and Business.
    2. Michaela Trippl & Joshua von Gabain & Franz Tödtling, 2006. "Policy agents as catalysts of knowledge links in the biotechnology sector," SRE-Disc sre-disc-2006_01, Institute for Multilevel Governance and Development, Department of Socioeconomics, Vienna University of Economics and Business.
    3. Bruce Rasmussen, 2010. "Innovation and Commercialisation in the Biopharmaceutical Industry," Books, Edward Elgar Publishing, number 13680.
    4. Ferretti, Marco & Guerini, Massimiliano & Panetti, Eva & Parmentola, Adele, 2022. "The partner next door? The effect of micro-geographical proximity on intra-cluster inter-organizational relationships," Technovation, Elsevier, vol. 111(C).
    5. Bettencourt, Luis M.A. & Lobo, Jose & Strumsky, Deborah, 2007. "Invention in the city: Increasing returns to patenting as a scaling function of metropolitan size," Research Policy, Elsevier, vol. 36(1), pages 107-120, February.
    6. Philip Cooke, 2004. "Life Sciences Clusters and Regional Science Policy," Urban Studies, Urban Studies Journal Limited, vol. 41(5-6), pages 1113-1131, May.
    7. Maureen McKelvey & Bastian Rake, 2012. "Research Network Position and Innovative Performance: Evidence from the Pharmaceutical Industry," Jena Economics Research Papers 2012-021, Friedrich-Schiller-University Jena.
    8. Koen Frenken & Roderik Ponds & Frank Van Oort, 2010. "The citation impact of research collaboration in science‐based industries: A spatial‐institutional analysis," Papers in Regional Science, Wiley Blackwell, vol. 89(2), pages 351-271, June.
    9. Gambardella, Alfonso & Orsenigo, Luigi & Pammolli, Fabio, 2000. "Global Competitiveness in Pharmaceuticals: A European Perspective," MPRA Paper 15965, University Library of Munich, Germany.
    10. Kolympiris, Christos & Kalaitzandonakes, Nicholas & Miller, Douglas, 2011. "Spatial collocation and venture capital in the US biotechnology industry," Research Policy, Elsevier, vol. 40(9), pages 1188-1199.
    11. Gilding, Michael & Brennecke, Julia & Bunton, Vikki & Lusher, Dean & Molloy, Peter L. & Codoreanu, Alex, 2020. "Network failure: Biotechnology firms, clusters and collaborations far from the world superclusters," Research Policy, Elsevier, vol. 49(2).
    12. Bas Karreman & Martijn J. Burger & Fred van Eenennaam, 2019. "Revealed competition between cluster organizations: An exploratory analysis of the European life sciences sector," Environment and Planning A, , vol. 51(3), pages 705-723, May.
    13. Poh-Kam Wong, 2007. "Commercializing biomedical science in a rapidly changing “triple-helix” nexus: The experience of the National University of Singapore," The Journal of Technology Transfer, Springer, vol. 32(4), pages 367-395, August.
    14. Christos Kolympiris & Nicholas Kalaitzandonakes, 2013. "Geographic scope of proximity effects among small life sciences firms," Small Business Economics, Springer, vol. 40(4), pages 1059-1086, May.
    15. Sharmistha Bagchi-Sen, 2006. "Strategic Considerations for Innovation and Commercialization in the US Biotechnology Sector," European Planning Studies, Taylor & Francis Journals, vol. 15(6), pages 753-766, May.
    16. Kolympiris, Christos & Kalaitzandonakes, Nicholas & Miller, Douglas, 2014. "Public funds and local biotechnology firm creation," Research Policy, Elsevier, vol. 43(1), pages 121-137.
    17. Alessandro Rosiello & Stuart Parris, 2009. "The patterns of venture capital investment in the UK bio-healthcare sector: the role of proximity, cumulative learning and specialisation," Venture Capital, Taylor & Francis Journals, vol. 11(3), pages 185-211, February.
    18. Christian Zeller, 2010. "The Pharma-biotech Complex and Interconnected Regional Innovation Arenas," Urban Studies, Urban Studies Journal Limited, vol. 47(13), pages 2867-2894, November.
    19. Guido Capaldo & Margarida Fontes & Lorella Cannavacciuolo & Pierluigi Rippa & Cristina Sousa, 2015. "Networks Mobilized to Access Key Resources at Early Stages of Biotech Firms: A Comparative Analysis in Two Moderately Innovative Countries," European Planning Studies, Taylor & Francis Journals, vol. 23(7), pages 1381-1400, July.
    20. Boeker, Warren & Howard, Michael D. & Basu, Sandip & Sahaym, Arvin, 2021. "Interpersonal relationships, digital technologies, and innovation in entrepreneurial ventures," Journal of Business Research, Elsevier, vol. 125(C), pages 495-507.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:elg:eechap:13300_5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Darrel McCalla (email available below). General contact details of provider: http://www.e-elgar.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.